Literature DB >> 18059230

Immunohistochemistry of choriocarcinoma: an aid in differential diagnosis and in elucidating pathogenesis.

Tsui-Lien Mao1, Robert J Kurman, Chao-Cheng Huang, Ming-Chieh Lin, Ie-Ming Shih.   

Abstract

Choriocarcinoma is traditionally described as being composed of cytotrophoblast and syncytiotrophoblast. Microscopically, these 2 types of cells are intimately associated with each other, forming a characteristic biphasic plexiform pattern, however, the nature of these 2 types of trophoblastic cells is not well understood. In this study, we used immunohistochemistry for several trophoblastic markers to analyze the trophoblastic subpopulations in 36 gestational choriocarcinomas. Eighty-one specimens including placenta, complete mole, placental site nodule, epithelioid trophoblastic tumor, and placental site trophoblastic tumor were analyzed. The antibodies included Mel-CAM, HLA-G, MUC-4, and beta-catenin. A semiquantitative assessment of positive cells and the cellular localization of these markers were recorded. We found diffuse strong membranous and cytoplasmic staining for MUC-4 in mononucleate cells in all 36 cases (100%) and a similar pattern of localization in 28 cases (78%) for HLA-G. This distribution was similar to that in normal placentas, where MUC-4 and HLA-G are expressed in the trophoblastic cells of the trophoblastic columns and implantation site. In choriocarcinoma, mononucleate trophoblastic cells showed moderate immunoreactivity for Mel-CAM, a specific marker for implantation site intermediate trophoblast, in 78% of the cases. The MUC-4, HLA-G, and Mel-CAM-positive trophoblastic cells were larger than cytotrophoblastic cells, with more abundant cytoplasm, consistent with the morphology of intermediate trophoblast. In contrast, 31% of the choriocarcinomas contained a very small proportion (<5%) of mononucleate trophoblastic cells compatible with cytotrophoblast that was positive for nuclear beta-catenin, a cytotrophoblast-associated marker. These results suggest that choriocarcinoma is composed predominantly of a mixture of syncytiotrophoblast and intermediate trophoblast with only a small proportion of cytotrophoblast. The presence of nuclear beta-catenin staining in the cytotrophoblast of choriocarcinoma is consistent with the view that choriocarcinoma develops from transformed cytotrophoblastic cells which are presumably the cancer stem cells that differentiate into either intermediate trophoblast or syncytiotrophoblast.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18059230     DOI: 10.1097/PAS.0b013e318058a529

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  16 in total

1.  Power of the eternal youth: Nanog expression in the gestational choriocarcinoma.

Authors:  Ie-Ming Shih; Kuan-Ting Kuo
Journal:  Am J Pathol       Date:  2008-08-28       Impact factor: 4.307

2.  Low molecular weight hyaluronan induces migration of human choriocarcinoma JEG-3 cells mediated by RHAMM as well as by PI3K and MAPK pathways.

Authors:  Marilina Mascaró; Matías A Pibuel; Silvina L Lompardía; Mariangeles Díaz; Elsa Zotta; Maria I Bianconi; Néstor Lago; Silvina Otero; Gustavo Jankilevich; Elida Alvarez; Silvia E Hajos
Journal:  Histochem Cell Biol       Date:  2017-04-01       Impact factor: 4.304

3.  GATA-3 expression in trophoblastic tissues: an immunohistochemical study of 445 cases, including diagnostic utility.

Authors:  Natalie Banet; Allen M Gown; Ie-Ming Shih; Qing Kay Li; Richard B S Roden; Marisa R Nucci; Liang Cheng; Christopher G Przybycin; Niloofar Nasseri-Nik; Lee-Shu-Fune Wu; George J Netto; Brigitte M Ronnett; Russell Vang
Journal:  Am J Surg Pathol       Date:  2015-01       Impact factor: 6.394

Review 4.  Impact of HLA-G analysis in prevention, diagnosis and treatment of pathological conditions.

Authors:  Daria Bortolotti; Valentina Gentili; Antonella Rotola; Enzo Cassai; Roberta Rizzo; Dario Di Luca
Journal:  World J Methodol       Date:  2014-03-26

Review 5.  Epithelioid trophoblastic tumor after induced abortion with previous broad choriocarcinoma: a case report and review of literature.

Authors:  Xiaofei Zhang; Haiyan Shi; Xiaoduan Chen
Journal:  Int J Clin Exp Pathol       Date:  2014-10-15

6.  Lack of a y-chromosomal complement in the majority of gestational trophoblastic neoplasms.

Authors:  Kai Lee Yap; Michael J Hafez; Tsui-Lien Mao; Robert J Kurman; Kathleen M Murphy; Ie-Ming Shih
Journal:  J Oncol       Date:  2010-02-21       Impact factor: 4.375

7.  Expression of glypican 3 in placental site trophoblastic tumor.

Authors:  Robin J Ou-Yang; Pei Hui; Ximing J Yang; Debra L Zynger
Journal:  Diagn Pathol       Date:  2010-09-25       Impact factor: 2.644

Review 8.  Review of the adenocarcinoma cell surface receptor for human alpha-fetoprotein; proposed identification of a widespread mucin as the tumor cell receptor.

Authors:  G J Mizejewski
Journal:  Tumour Biol       Date:  2013-02-28

Review 9.  Coexisting epithelioid trophoblastic tumor and placental site trophoblastic tumor of the uterus following a term pregnancy: report of a case and review of literature.

Authors:  Xiaofei Zhang; Caiyun Zhou; Minghua Yu; Xiaoduan Chen
Journal:  Int J Clin Exp Pathol       Date:  2015-06-01

10.  Transformation of a post-cesarean section placental site nodule into a coexisting epithelioid trophoblastic tumor and placental site trophoblastic tumor: a case report.

Authors:  Bo-Jung Chen; Chien-Jui Cheng; Wei-Yu Chen
Journal:  Diagn Pathol       Date:  2013-05-20       Impact factor: 2.644

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.